A Non-farnesylated Ha-Ras Protein Can Be Palmitoylated and Trigger Potent Differentiation and Transformation by Booden, Michelle A. et al.
A Non-farnesylated Ha-Ras Protein Can Be Palmitoylated and
Trigger Potent Differentiation and Transformation*
(Received for publication, June 19, 1998, and in revised form, September 28, 1998)
Michelle A. Booden‡, Tara L. Baker§, Patricia A. Solski¶, Channing J. Der¶, Steven G. Punke‡,
and Janice E. Buss‡i
From the Departments of ‡Biochemistry and §Zoology and Genetics, Iowa State University, Ames, Iowa 50011 and the
¶Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina 27599
Ha-Ras undergoes post-translational modifications
(including attachment of farnesyl and palmitate) that
culminate in localization of the protein to the plasma
membrane. Because palmitate is not attached without
prior farnesyl addition, the distinct contributions of the
two lipid modifications to membrane attachment or bi-
ological activity have been difficult to examine. To test if
palmitate is able to support these crucial functions on
its own, novel C-terminal mutants of Ha-Ras were con-
structed, retaining the natural sites for palmitoylation,
but replacing the C-terminal residue of the CAAX signal
for prenylation with six lysines. Both the Ext61L and
ExtWT proteins were modified in a dynamic fashion by
palmitate, without being farnesylated; bound to mem-
branes modestly (40% as well as native Ha-Ras); and
retained appropriate GTP binding properties. Ext61L
caused potent transformation of NIH 3T3 cells and, un-
expectedly, an exaggerated differentiation of PC12 cells.
Ext61L with the six lysines but lacking palmitates was
inactive. Thus, farnesyl is not needed as a signal for
palmitate attachment or removal, and a combination of
transient palmitate modification and basic residues can
support Ha-Ras membrane binding and two quite differ-
ent biological functions. The roles of palmitate can
therefore be independent of and distinct from those of
farnesyl. Reciprocally, if membrane association can be
sustained largely through palmitates, farnesyl is freed
to interact with other proteins.
In its GTP-bound conformation, Ha-Ras activates several
signal transduction cascades that control gene expression and
actin cytoskeleton organization. The most well studied of these
pathways, the Raf/mitogen-activated protein kinase cascade,
involves a series of cytoplasmic serine/threonine kinases; an-
other utilizes several members of the Rho family of GTP-bind-
ing proteins that regulate cell morphology. In NIH 3T3 mouse
fibroblast cells, activated forms of Ha-Ras induce mitogenesis
and transformation; in the rat pheochromocytoma cell line
PC12, Ha-Ras activation triggers neuronal differentiation.
More important, membrane localization of Ha-Ras is critical for
either of these distinct biological activities. One important con-
sequence of membrane binding is to enable Ha-Ras to act as a
GTP-dependent, membrane-localized docking site for effector
proteins, such as Raf kinase.
The correct targeting of Ha-Ras to the inner surface of the
plasma membrane requires a series of post-translational mod-
ifications at the protein’s C terminus. These reactions include
attachment of the isoprenoid farnesyl to a cysteine residue
(Cys-186) located four residues from the C terminus, followed
by removal of the C-terminal tripeptide and methylation of the
newly exposed carboxyl group of the farnesylated cysteine (1).
The final step is palmitoylation of two nearby C-terminal cys-
teines (Cys-181 and Cys-184) (2, 3).
The duties of these lipids has been inferred principally from
mutant Ras proteins that lack the palmitates, but retain the
isoprenoid, or that lack all three lipids entirely. The decreased
membrane binding observed with these modification mutants
has led to the model that membrane binding is a primary role
for the lipids attached to Ha-Ras. However, the function(s) of
farnesyl and palmitate, individually, have not been completely
elucidated.
The consequences of farnesyl attachment are particularly
important because prenylation is the first step in processing,
putting farnesylation in temporal control of subsequent modi-
fications. Without an isoprenoid attached to Cys-186, the Ha-
Ras protein remains soluble, and the adjacent Cys-181 and
Cys-184 do not become palmitoylated. An isoprenoid has been
shown to be a prerequisite modification for recognition by both
the membrane-bound protease and methylase enzymes, which
further modify the C terminus (4, 5). It has been suggested that
a putative palmitoyl acyltransferase may also require the pres-
ence of a farnesyl group (6), but the authenticity of this enzy-
matic activity has not been confirmed. Farnesyl thus functions
in maturation of Ras proteins by acting as part of a signal
sequence for and allowing interaction of Ras with at least two
membrane-bound processing enzymes.
The most well recognized role for farnesyl is its participation
in Ras membrane binding. Prenylation is required for initiat-
ing the transition of the cytosolic precursor to the membrane-
bound form. Whether farnesyl also plays a role in sustaining or
directing submembrane localization has not been clarified. Far-
nesyl by itself does not confer high affinity membrane binding
to Ras peptides in vitro (7–9), nor does it suffice for targeting of
the protein to plasma membranes in intact cells (10–12). The
farnesyl group appears to depend heavily on a second mecha-
nism to assist its efforts in membrane binding. Two types of
“secondary” membrane-binding signals have been identified: a
hydrophobic type involving palmitoylation of nearby cysteine
residues, as is found in Ha-Ras, N-Ras, and Ki-Ras4A; and an
ionic type, based on the series of basic residues just N-terminal
of the CAAX sequence, as found in Ki-Ras4B (2, 13).
A number of studies have now suggested that farnesyl may
have an additional role besides initiating membrane attach-
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ment. The farnesyl group is proposed to bind to specific mem-
brane proteins (14), a process that might enhance Ras/mem-
brane interaction or that might be needed for activation of Ras
effector proteins. Good evidence has been presented that a
structural or conformational epitope found in the prenylated
form of Ha-Ras is important (in addition to the role of Ras in
Raf membrane targeting) for activation of Raf-1 through the
kinase’s cysteine-rich zinc finger domain (15–17). In vitro anal-
ysis has suggested that farnesylation of Ha-Ras may also be
needed for human SOS1 to promote guanine nucleotide ex-
change (18). Earlier studies using an activated yeast Ras2
protein revealed that mutation of the farnesylation site de-
creased the interaction between Ras2 and adenylyl cyclase (19,
20). Thus, these studies imply that the prenyl structure of Ras
may be involved in and perhaps required for specific associa-
tions of Ha-Ras and its regulatory or target proteins. How
potential roles in both lipid bilayer binding and protein inter-
actions can be performed simultaneously or sequentially re-
mains an important, unanswered question.
The duties for which the palmitates of Ha-Ras are used are
much less clear. Palmitate certainly has sufficient hydropho-
bicity to support membrane binding of an Ha-Ras protein, but
the requirement for prior farnesylation has prevented study of
the role(s) of the Ha-Ras palmitates independent of isoprenoid.
It is possible that palmitoylation of Cys-181 and Cys-184 of
Ha-Ras is only a nonspecific (although required) secondary
membrane attachment signal that simply enables more sub-
stantial or sustained levels of membrane binding of a farnesy-
lated Ha-Ras protein. More direct, biochemical studies of
palmitoylation have been thwarted because the enzymes that
might attach palmitates to Ha-Ras, or similar proteins, have
proved to be extremely difficult to isolate (6, 21, 22). In vivo
requirements for palmitate attachment have been examined in
a large series of C-terminal mutant Ha-Ras proteins, all of
which became palmitoylated (11). These studies identified
amino acids that appeared to be novel signals for intracellular
trafficking, but no consensus sequence for palmitate attach-
ment was found. However, these mutant proteins still retained
an intact CAAX motif and were farnesylated, so it remained
possible that farnesyl might be part of an otherwise enigmatic
signal for palmitoylation. Because several of these farnesylated
and palmitoylated mutant Ha-Ras proteins were mis-localized
to internal membranes within the cell, one clear result was that
acquisition of both C-terminal lipids is not sufficient to assure
correct plasma membrane targeting.
However, based on observations that C181S/C184S mutants
of Ha-Ras (which retain farnesyl but lack palmitate) localize
poorly to the plasma membrane, several studies have sug-
gested that it is palmitate rather than farnesyl that is largely
responsible for Ha-Ras membrane binding. In the Xenopus
oocyte maturation assay and also in transformation of NIH 3T3
cells, Ha-Ras proteins modified only by farnesyl have poor
biological activity, indicating that acquisition of palmitates is
important functionally (9–11, 23, 24). Using a yeast plasmid-
loss assay, Mitchell et al. (25) studied a series of yeast Ras2
proteins that showed that the combined effect of C-terminal
basic amino acids and palmitoylation of cysteine residues was
sufficient to support Ras-dependent growth, independent of
prenylation. More important, the biological function of these
yeast Ras2 proteins correlated with their ability to be palmi-
toylated. These results show that palmitate is an important
contributor to Ha-Ras membrane binding and function and
imply that, despite its chronological precedence, farnesyl de-
pends upon palmitate to support these activities. However, it
remains unclear whether palmitate mutually requires the far-
nesyl or plays an independent but complementary role in spe-
cific membrane association and biological activity of Ha-Ras.
To enable study of requirements for palmitate addition and
to determine if palmitates could direct specific plasma mem-
brane targeting, sustain Ha-Ras membrane binding, and sup-
port biological function, a novel mammalian Ha-Ras protein
was constructed, designed to have C-terminal palmitates, but
no isoprenoid. The results indicate that, although farnesyl
needs the assistance of palmitate for membrane binding and
full biological function, palmitates can support substantial far-
nesyl-independent activity. The results begin to define distinct
roles for Ha-Ras farnesyl and palmitate and suggest that
palmitate is more than just an energetic form of membrane
tether that serves the needs of the farnesyl and may have
unique and dynamic biological roles of its own.
MATERIALS AND METHODS
Mutants and Plasmids—Ext61L, ExtWT, Ext61L(C181S/C184S/
C186S), ExtWT(C181S/C184S/C186S), and Ha-Ras61L were expressed
from pcDNA3 (Invitrogen, Carlsbad, CA). To construct Ext61L, an
S190K substitution followed by the addition of five lysine residues was
introduced into Ha-Ras with a Q61L activating mutation by oligonucle-
otide-directed polymerase chain reaction mutagenesis. The construc-
tion used an oligonucleotide 59-GGGGGGATCCACCATGACAGAATA-
CAAGCTT-39, which was fully complementary to the 59-sequences of
human Ha-Ras, and the mutagenic oligonucleotide 59-GGGGGGATCC-
TCACTTCTTCTTCTTCTTCTTGAGCACACACTTGCAGCT-39, which
reproduced the nucleotides complementary to the 39-sequences of Ha-
Ras and introduced the six lysine codons (underlined), a termination
codon, and a BamHI restriction enzyme recognition site. The resulting
pcDNA3-Ext61L cDNA was inserted as a BamHI fragment into the
BamHI site of pcDNA3 and encoded the complete Ha-Ras protein with
a C-terminal polylysine tail (Fig. 1A). pcDNA3-ExtWT is identical to
pcDNA3-Ext61L, except that it encodes the non-activated cellular form
of Ha-Ras with the normal glutamine residue at position 61.
Ext61L(C181S/C184S/C186S) and ExtWT(C181S/C184S/C186S) were
constructed in a similar fashion using the mutagenic oligonucleotide
59-GTACTCTAGATCACTTCTTCTTCTTCTTTTTTAACACACTCTTA-
CTGCTCATAGAGCCAGGACC-39 to introduce the six lysine codons
(underlined) and to change codons 181, 184, and 186 from Cys to Ser
(double underlined). The cDNA was inserted as a BamHI-NotI frag-
ment into pcDNA3.
Cell Culture, Transfection, and Transformation Assays—PC12 cells
were maintained at 5% CO2 in RPMI 1640 medium supplemented with
10% heat-inactivated horse serum and 5% fetal calf serum (both from
Hyclone Laboratories, Logan, UT) . Twenty-four hours before DNA
transfection, PC12 cells were plated onto laminin (10 mg/ml; Life Tech-
nologies, Inc.)-coated 60-mm tissue culture dishes at a density of 106
cells/dish and grown overnight. Transfection was performed using Li-
pofectAMINE reagent (Life Technologies, Inc.) as described by the
manufacturer. NIH 3T3 cells were grown at 10% CO2 in Dulbecco’s
modified Eagle’s medium supplemented with 10% calf serum (Hyclone
Laboratories). Cells were transfected with plasmid DNAs encoding
Ext61L or ExtWT Ras proteins using the calcium phosphate precipita-
tion technique (11, 26). Transformed foci were quantified after 7–14
days. Transfected cells were also selected in growth medium containing
G418 (Geneticin, Life Technologies, Inc.) at 500 mg/ml to establish cell
lines that stably expressed the mutant proteins.
Preparation of Subcellular Fractions—Subcellular fractions were
prepared by lysis of cells in hypotonic buffer (0.1 M Tris, pH 7.4, 0.5 M
MgCl2, 1 mM Pefabloc, 1 mM leupeptin, 2 mM pepstatin, and 0.1%
aprotinin (Calbiochem)) and addition of NaCl to adjust the ionic
strength to 0.15 M, followed by ultracentrifugation for 30 min at
100,000 3 g as described previously (26). Hydrophobic (e.g. lipid-mod-
ified) proteins were isolated by separation into detergent (hydrophobic)
and aqueous (hydrophilic) fractions by Triton X-114 lysis and phase
separation as described (2). For testing release of proteins from the
P100 membrane fraction, the supernatant (S100 5 S1) was set aside,
and the pellet was resuspended in 1 ml of hypotonic buffer supple-
mented with 0.5 M NaCl and incubated on ice for 30 min. The suspen-
sion was centrifuged at 100,000 3 g; the supernatant (S2) was collected;
and the pellet was incubated with the high salt buffer a second time and
centrifuged, yielding a third supernatant (S3). The pellet from the
second salt wash (P3) was resuspended in 1 ml of radioimmune precip-
itation assay buffer and centrifuged, and the radioimmune precipita-
tion assay extract (S4) removed. The proteins in the separate S1–S4
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supernatants were precipitated with 10 ml of acetone for 1 h at 4 °C,
collected by centrifugation at 3000 rpm for 30 min, and dissolved in 100
ml of electrophoresis sample buffer. Equal volumes of each fraction were
separated by SDS-PAGE.1
Radiolabeling, Immunoprecipitation, and Immunoblotting—For pro-
tein labeling, cells were incubated with 200 mCi/plate Tran35S-label
(ICN, Costa Mesa, CA) in Dulbecco’s modified Eagle’s medium lacking
cysteine/methionine for 18 h. To examine isoprenoid attachment, cells
were pretreated with 50 mM compactin for 30 min and then labeled for
18 h with 100 mCi/ml [3H]mevalonolactone (American Radiolabeled
Chemicals, St. Louis, MO) in the continued presence of compactin (27).
Palmitate incorporation and subsequent depalmitoylation were meas-
ured by labeling cells for 4 h with 1 mCi/ml [3H]palmitate (NEN Life
Science Products) in medium containing nonessential amino acids, 25
mg/ml cycloheximide, and 10% calf serum and then incubating for
varying times in nonradioactive medium containing 200 mM palmitic
acid. After radiolabeling, samples were prepared for subcellular frac-
tionation as described above, or cells were lysed directly in high SDS/
radioimmune precipitation assay buffer (50 mM Tris, pH 7.0, 0.5% SDS,
1% Nonidet P-40, 1% sodium deoxycholate, 150 mM NaCl, and 50 mM
aprotinin (Calbiochem)) for immunoprecipitation. Extracts of cell frac-
tions were incubated on ice for 1 h with Ha-Ras-specific mouse mono-
clonal antibody 146-3E4 (Quality Biotech Inc., Camden, NJ).
Immune complexes were recovered with Staphylococcus aureus cells
(Pansorbin, Calbiochem) coated with goat anti-mouse heavy and light
chain IgG; washed; resuspended in special sample buffer (2% SDS, 10
mM NaPO4, pH 7.0, 10% glycerol, 0.05% dithiothreitol, and 0.02%
bromphenol blue); resolved by SDS-PAGE; transferred to polyvinyli-
dene difluoride membrane; and, as needed, sprayed with EN3HANCE
(NEN Life Science Products) for fluorography or developed for immu-
noblot analysis. For immunoblotting, after separation by SDS-PAGE,
proteins were transferred electrophoretically to polyvinylidene difluo-
ride membranes, and nonspecific protein binding was blocked by incu-
bating the membrane in 1.25% nonfat dry milk in Tris-buffered saline.
Membranes were probed with Ha-Ras-specific monoclonal antibody
146-3E4. Biotinylated secondary antibodies (anti-mouse; Vector Lab-
oratories, Inc., Burlingame, CA) were used with development by alka-
line phosphatase (Vector Laboratories, Inc.) using the manufacturer’s
protocol.
Immunofluorescence—PC12 cells were plated at low density on se-
rum-coated coverslips in six-well dishes and transfected with Ext61L
DNA as described above. Following fixation with freshly prepared 2%
paraformaldehyde, cells were treated with a blocking solution contain-
ing 0.4% bovine serum albumin and 3% horse serum to block nonspe-
cific antibody interactions and 0.05% Triton X-100 and 0.05% Tween 20
to permeabilize the cells (28). Cells were then treated with a 1:20
dilution of Ha-Ras-specific rat monoclonal antibody Y13-172, followed
by a 1:50 dilution of fluorescein isothiocyanate-conjugated rabbit anti-
rat secondary antibody (Cappel/Organon-Teknika, Durham, NC), both
diluted in blocking solution; mounted in diazabicyclo[2.2.2]octane/glyc-
erol solution to prevent fading; and viewed by confocal microscopy.
GTP/GDP Determination—Confluent cultures of PC12 cells were
grown overnight in 1% dialyzed calf serum. Cells were then radiola-
beled with 0.5–1 mCi/ml 32Pi (NEN Life Science Products) for 4 h in
phosphate-free medium containing 1% calf serum. Cells were rinsed
with phosphate-buffered saline and lysed in 0.6 ml of cold GTP lysis
buffer containing 50 mM Tris-HCl, pH 7.4, 20 mM MgCl2, 150 mM NaCl,
0.5% (v/v) Nonidet P-40, 20 mg/ml aprotinin, 1 mM EGTA, and 1 mM
Na3VO4. Insoluble material was removed by centrifugation at 750 3 g
for 3 min. Supernatants were cleared with 50% (v/v) bovine serum
albumin-coated charcoal in lysis buffer, and then Ha-Ras proteins were
captured by immunoprecipitation using GTP lysis buffer. Ha-Ras and
its bound nucleotides were eluted by heating to 60 °C for 5 min in a
minimal volume of buffer containing 20 mM Tris-HCl, pH 7.4, 2 mM
EDTA, 2% (w/v) SDS, 2 mM GDP, and 2 mM GTP. The eluants were
cleared by centrifugation at 10,000 3 g for 5 min, and then samples
were spotted on polyethyleneimine cellulose plates (J. T. Baker Inc.)
and separated with 0.75 M KH2PO4, pH 3.4. Plates were dried and
exposed to preflashed film using screen enhancers. The film images of
GDP and GTP were scanned and quantified using the program Image-
Quant (Molecular Dynamics, Inc.), and the percent of an Ha-Ras pro-
tein that contained bound GTP was calculated using the following
formula: % with GTP 5 GTP/(GTP 1 1.5 GDP).
RESULTS
Ext61L cDNA Produces a Stable Protein That Is Not Preny-
lated—Multiple studies that had examined a great many mu-
tations within and immediately N-terminal of the CAAX box of
non-prenylated Ha-Ras or Ki-Ras4B proteins had all failed to
detect membrane binding (a biochemical surrogate for poten-
tial palmitoylation). The only successful examples of palmitoy-
lated forms that lacked isoprenoid were the yeast Ras2 mu-
tants in which the CAAX box was extended with a series of
basic amino acid residues (25). This work had suggested that
lengthening and introducing positively charged residues en-
abled a yeast Ras2 protein to contact membranes and to be-
come palmitoylated. The mammalian ExtRas proteins were
therefore designed with a lysine in the X position of the CAAX
box, which was anticipated would produce a nonfunctional
prenylation motif, and five additional lysine residues to provide
an ionic platform for interaction with acidic membrane
phospholipids.
The initial experiments determined the stability and size of
the Ext61L protein and whether the carboxyl-terminal CV-
LKKKKKK sequence (Fig. 1A) prevented the Ext61L protein
from being prenylated. This was important because it was
possible the Ext61L protein would be vulnerable to proteolytic
removal of these basic residues, which would remove the struc-
ture that was meant to initiate and assist membrane binding.
Also, removal of five lysines would potentially recreate a CAAX
box motif (CVLK) that might permit prenylation. This was not
considered likely as the presence of a lysine at the X position
had previously been found to prevent prenylation of a Ki-Ras4B
protein (29). If such trimming and prenylation were to occur, it
could be detected because it would produce a smaller protein,
similar in size to mature native Ha-Ras protein. An additional
way to detect, indirectly, if prenylation was occurring was to
treat cells with compactin. Compactin inhibits isoprenoid syn-
thesis and hence decreases Ras prenylation, preventing the1 The abbreviation used is: PAGE, polyacrylamide gel electrophoresis.
FIG. 1. Post-translational processing of Ext61L. A, shown are the
amino acid sequences of the C termini of the Ha-Ras61L and Ext61L
proteins. B, NIH 3T3 cells transfected with Ext61L or empty vector
(mock) were metabolically labeled with [35S]methionine/cysteine for
18 h in the presence or absence of 50 mM compactin. The cell lysate was
then separated into crude soluble (S) and particulate (P) fractions.
Labeled proteins were immunoprecipitated from each fraction, resolved
by SDS-PAGE, and detected by fluorography. Endogenous Ha-Ras pro-
teins are indicated by the arrowhead. C, parallel cultures of COS cells
expressing Ha-Ras61L (lane 1) or Ext61L (lane 2) were metabolically
labeled with [3H]mevalonic acid for 18 h in the presence of 50 mM
compactin. Immunoprecipitates were resolved by SDS-PAGE and
transferred to polyvinylidene difluoride membrane, and radiolabel was
detected by fluorographic exposure for 14 days.
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change in mobility and leading to the accumulation of the
unmodified precursor form of Ha-Ras in the cytosol (1).
To test these possibilities, COS cells expressing Ext61L were
labeled metabolically with [35S]methionine in the presence or
absence of compactin. Cytosolic and membrane-containing
fractions were prepared, and proteins were separated by SDS-
PAGE and detected by fluorography. The Ext61L protein was
easily detected and had the appropriate, slightly slower mobil-
ity than the endogenous Ha-Ras protein of COS cells, indicat-
ing that the C-terminal residues of Ext61L were retained (Fig.
1B). More important, a significant portion (40%) of the Ext61L
protein was detected in the membrane-containing fraction and
had the same apparent size as the cytosolic protein. This sim-
ilarity in size of proteins in the S100 and P100 fractions indi-
cated indirectly that the extension protein was not farnesy-
lated. In addition, compactin did not decrease the amount of
Ext61L protein that was present in the P100 fraction. Without
compactin treatment, .90% of the small amount of endogenous
Ha-Ras protein in untransfected or transfected COS cells (Fig.
1B) was found in the membrane fraction. In the compactin-
treated cells, the amount of membrane-bound endogenous Ha-
Ras decreased; the increased amount of the precursor form in
the cytosol was obscured by the large amount of soluble Ext61L
protein.
To evaluate more directly whether the Ext61L protein re-
mained unmodified by isoprenoid, COS cells expressing this
protein or Ha-Ras61L were labeled with [3H]mevalonic acid,
and the Ras proteins were isolated by immunoprecipitation. No
incorporation of radioactivity could be detected in the Ext61L
lane (Fig. 1C, lane 2). However, labeling of cells expressing
Ha-Ras61L confirmed that an Ha-Ras protein with an intact
CAAX motif could be prenylated (Fig. 1C, lane 1). In addition,
immunoblot detection of the same membrane confirmed that
the Ext61L protein was expressed (data not shown). These
results indicated that the Ext61L protein was not prenylated.
Ext61L Binds Membranes Rapidly and Is Targeted to the
Plasma Membrane—Although a significant amount of Ext61L
protein was found in the membrane-containing fraction in the
cells, the extent of binding of the Ext61L protein was far less
than the .95% binding attained by endogenous Ha-Ras with
the natural version of the C terminus. Previously constructed
C-terminal mutants of v-Ha-Ras had also shown decreased or
delayed membrane binding compared with v-Ha-Ras with the
normal C-terminal residues and modifications (11). To examine
if the decreased membrane association of Ext61L reflected
inefficient trafficking or attachment to membranes, the speed
with which newly synthesized Ext61L traversed the cytosol
and achieved membrane association was assessed. Replicate
dishes of cells were metabolically labeled with [35S]methionine/
cysteine for 10 min, and then one plate was incubated in
nonradioactive medium for an additional 30 min. Subcellular
fractions were prepared, and Ha-Ras immunoprecipitates were
formed. Within the 10-min pulse period, 27% of the newly
synthesized Ext61L protein had already translocated to the
membrane (Fig. 2A). After the 30-min chase, Ext61L in the
membrane-containing fraction had increased to 44% of the
total protein and therefore to the same level seen at steady
state. This speed of membrane binding was similar to or even
faster than that seen with a v-Ha-Ras protein that undergoes
both farnesylation and palmitoylation (11). The addition of the
basic residues to Ext61L therefore did not impede normal traf-
ficking or delay membrane attachment.
Some of the previously mentioned v-Ha-Ras C-terminal mu-
tants, which by biochemical fractionation techniques were
membrane-associated, were subsequently found to be mis-lo-
calized to internal rather than plasma membranes (11). This
intracellular trapping was correlated with poor biological ac-
tivity. As a more definitive way to assess attachment to specific
membranes, immunofluorescence was used to visualize the
subcellular localization of Ext61L in intact single cells. A series
of confocal laser microscopic images of PC12 cells expressing
Ext61L exhibited a clear defined signal of Ext61L at the
plasma membrane (Fig. 2B). No staining of internal mem-
branes was observed. These data, taken together with the
biochemical data described above, indicated that somewhat
less than half of the Ext61L protein succeeded in associating
with membranes and, more specifically, that these membrane-
bound molecules were located at the plasma membrane.
Ext61L Associates with Membranes Largely through Hydro-
phobic Interactions—The lysines at the terminus of ExtRas
were envisioned to participate in ionic interactions with acidic
phospholipids of the plasma membrane and thus to initiate
membrane binding that would enable palmitoylation. To deter-
mine if ionic forces might also contribute to maintenance of the
association between the Ext61L protein and cellular mem-
branes, addition of a concentrated salt solution to isolated
membranes was used to disrupt ionic interactions (2). Mem-
branes from transfected COS cells were first separated from
FIG. 2. Ext61L binds membranes rapidly and is located on
plasma membranes of PC12 cells. A, COS-1 cells transfected with
empty vector (Mock) or expressing the Ext61L protein were labeled with
[35S]methionine/cysteine for 10 min and then either lysed immediately
(0-min chase) or incubated in nonradioactive medium for an additional
30 min. The resulting lysates were separated into soluble (S) and
particulate (P) fractions; immunoprecipitates were formed with Ha-Ras
antibody; and proteins were resolved by SDS-PAGE. Labeled proteins
were detected by fluorography. The culture used to prepare the sample
for the 30-min chase point for Ext61L had fewer cells present than the
cultures used for the 0-min chase points. The arrowhead designates
endogenous Ha-Ras; the arrow indicates the Ext61L protein. B, PC12
cells were plated on serum-coated coverslips and transfected with 1 mg
of Ext61L DNA. After 2 days, the cells were fixed and permeabilized
and then treated with anti-Ras monoclonal antibody Y13-172 and flu-
orescein isothiocyanate-conjugated secondary antibody. Cells were
viewed by confocal fluorescence microscopy. Scale bar 5 40 mm. Dis-
played is a representative cell with multiple membrane projections and
outgrowths frequently observed in PC12 cells expressing Ext61L. More
than 100 cells that possessed neurite extensions were surveyed, and all
possessed similar plasma membrane-specific distribution of Ext61L.
The signal from endogenous Ha-Ras in untransfected cells was too low
to be detected (see Fig. 5a for morphology).
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the cytosol, suspended in 0.5 M NaCl for 60 min, and then again
isolated by sedimentation. Less than 10% of the membrane-
associated Ext61L protein was released by the salt extraction
procedure (S2) (Fig. 3A). The basic residues of Ext61L thus
appeared to contribute in only a small way to long-term stabil-
ity of membrane association.
Because ionic forces could not account for the substantial
amount of protein that partitioned into the P100 fraction at
steady state, the ability of detergent to extract the membrane-
bound Ext61L protein was used to further explore if the portion
of Ext61L that resisted salt washout was bound to membrane
through hydrophobic forces. The salt-washed membranes were
again washed with 0.5 M NaCl (S3) and then resuspended in
SDS-containing buffer. The detergent-released material (S4)
was separated from the residual detergent-insoluble material
by centrifugation. For Ext61L, ;75% of the membrane-associ-
ated protein was released after SDS extraction (S4) (Fig. 3A).
The palmitoylated and farnesylated endogenous Ha-Ras pro-
tein in untransfected COS cells resisted the salt washout and
was released by detergent in the S4 fraction.
To further determine if the Ext61L protein displayed any
hydrophobic character suggestive of a lipid modification, trans-
fected cells were also processed by Triton X-114 phase separa-
tion. This procedure separates cellular proteins, based on over-
all hydrophobic character, into either an aqueous (hydrophilic)
or detergent (hydrophobic) fraction. For the Ha-Ras protein,
whose amino acid sequence is hydrophilic, Triton X-114 phase
separation has been used to distinguish forms that have or that
lack lipids. Cytosolic (S100) and membrane-containing (P100)
fractions were prepared from PC12 cells expressing Ha-Ras61L
or Ext61L proteins. The membranes were further partitioned
by resuspending the P100 fraction in 1% Triton X-114 and
warming the sample to trigger phase separation. For the Ha-
Ras61L protein, with the native version of the C terminus, the
precursor form (not yet lipid-modified) was present in the cy-
tosol, whereas the mature Ha-Ras61L protein (farnesylated
and palmitoylated) appeared in the detergent phase (Fig. 3B).
For Ext61L, ;60% of the protein again was cytosolic, and
roughly half of the ;40% of the protein that sedimented in the
P100 fraction (in multiple experiments, varying from 15 to 25%
of the total protein) further partitioned into the detergent
phase, suggesting that this minor portion of the expressed
protein possessed hydrophobic character (Fig. 3B).
The Ext61L Protein Is Palmitoylated—The two cysteines
(Cys-181 and Cys-184) that are palmitoylated in the Ha-
Ras61L protein are retained in Ext61L, as is Cys-186, which is
normally modified by farnesyl. Thus, the Ext61L protein has
three potential sites for palmitate attachment. To determine
whether or not Ext61L was palmitoylated, NIH 3T3 cells ex-
pressing Ext61L and Ha-Ras61L, respectively, were labeled for
3 h with [3H]palmitate, followed by a chase in nonradioactive
medium. At the indicated times, immunoprecipitates were
formed, and palmitate labeling of the Ext61L and Ha-Ras61L
proteins was detected by fluorography. The Ext61L protein not
only incorporated palmitate, but did so at a rate similar to the
Ha-Ras61L protein; both required ;3 h for maximum
[3H]palmitate labeling (data not shown). During the chase, the
depalmitoylation rates for the two proteins were also similar
(Fig. 4). When immunoblotting was used to account for varia-
tions in Ras protein recovery in the samples on the membrane
(data not shown), both Ext61L and Ha-Ras61L lost half of their
incorporated palmitate between 2 and 4 h. Similar results were
also obtained using PC12 cells transiently expressing either
Ext61L or Ha-Ras61L (data not shown). The palmitoylated
form of the Ext61L protein was detected only in the membrane-
containing cellular fraction, with no evidence of a partially
(de)palmitoylated protein being released into the cytosol.2
Thus, although the Ext61L protein was not prenylated, it could
be palmitoylated, and the palmitate displayed an apparently
normal turnover rate. This indicated that the presence of the
polybasic domain did not prevent the Ext61L protein from
being accessible to either acylating or deacylating enzymes.
Ext61L Transforms NIH 3T3 Cells—Soluble Ha-Ras61L pro-
tein has been reported to act as a dominant-negative inhibitor
of Ha-Ras transformation of NIH 3T3 cells (30, 31), presumably
by binding and trapping effector proteins, such as the Raf-1
protein kinase, in the cytosol. Because a large amount of
2 M. A. Booden, unpublished data.
FIG. 3. Ionic and hydrophobic contributions to membrane
binding of Ext61L. A, untransfected and transfected COS cells were
separated into crude soluble (S1) and particulate fractions. Particulate
proteins were further separated by two sequential incubations in 0.5 M
NaCl and centrifugation to generate salt-released proteins (S2 and S3).
Proteins that were not released by the salt washes were extracted by
suspension in a buffer containing SDS and Nonidet P-40 and separated
a final time into detergent-soluble (S4) and -insoluble (P4, not shown)
fractions. Ha-Ras proteins were immunoprecipitated from each frac-
tion, resolved by SDS-PAGE, and detected by immunoblotting. The
arrowhead designates endogenous Ha-Ras. B, at 4 days post-transfec-
tion, PC12 cells transfected with 1 mg of Ha-Ras61L, 50 ng of Ext61L,
1 mg of Ext61L(C181S/C184S/C186S), or 1 mg of ExtWT(C181S/C184S/
C186S) DNA were separated into cytosolic (S) and particulate fractions.
The particulate fraction was further subjected to Triton X-114 parti-
tioning. All fractions were precipitated in cold acetone and resuspended
in 100 ml of electrophoresis sample buffer, and equal portions of the
cytosolic (S), aqueous (A), or detergent (D) phase were resolved by
SDS-PAGE. Ha-Ras proteins were detected by immunoblotting. Ext61L
is indicated by the arrow. The arrowhead marks the mature form of 61L
in the detergent fraction, and the asterisk marks the precursor form of
61L in the cytosolic fraction.
FIG. 4. Ext61L is palmitoylated and displays normal palmitate
turnover rates. G418-selected NIH 3T3 cell lines expressing either
Ha-Ras61L or Ext61L proteins were labeled for 4 h with [3H]palmitate
and then incubated for the indicated times in nonradioactive medium
containing 200 mM nonradioactive palmitate. The Ext61L proteins were
immunoprecipitated and resolved by SDS-PAGE, and incorporated
[3H]palmitate was detected by fluorography. The Ras proteins on the
membrane were then detected by immunoblotting (data not shown) to
allow [3H]palmitate incorporation to be normalized for protein recovery.
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Ext61L was cytosolic, it was possible that the biological effec-
tiveness of Ext61L would be dampened by this pool of cytosolic
protein. The ability of the Ext61L protein to stimulate mito-
genesis and transformation of NIH 3T3 cells was examined to
ascertain if the combination of palmitate and basic residues
was capable of supporting a biological function of Ha-Ras.
Ext61L DNA was potently transforming and caused robust
focus formation (;1100 foci/mg of DNA) (Table I). This activity
was equivalent to the transforming activity of DNA encoding
the Ha-Ras61L form with the native lipid modifications. The
cellular version of the ExtRas protein, ExtWT, did not cause
focus formation in NIH 3T3 cells, even when the cells were
transfected with up to 2 mg of DNA. This lack of activity was
similar to the low transforming activity of the normally lipi-
dated form of Ha-Ras, p21WT. The morphology of transfected
NIH 3T3 cells expressing Ext61L was easily distinguished from
that of cells expressing the normally lipidated 61L protein: foci
produced by 61L were typically swirling, spreading colonies of
transformed cells, whereas the Ext61L-induced foci contained
clumps of cells that tended to round up and pull away from the
plastic substratum and contained unusually long, spindle-
shaped, elongated cells with a refractile appearance (data not
shown).
To determine if Ext61L expression also triggered anchorage-
independent growth, NIH 3T3 cells stably expressing Ha-
Ras61L or Ext61L were plated in soft agar and assayed for the
ability to form colonies. Like Ha-Ras61L-transformed cells,
Ext61L-transformed cells readily formed colonies in soft agar
(data not shown). All together, these results demonstrated that
the non-prenylated but palmitoylated Ext61L protein produced
the aberrant growth properties characteristic of an oncogenic
Ha-Ras protein in NIH 3T3 cells.
Ext61L Causes Neurite Extension in PC12 Cells—Transfor-
mation of NIH 3T3 cells is a hallmark of oncogenic Ha-Ras
activity that culminates in focus formation. To assess a differ-
ent aspect of Ras biological function, the ability of the Ext61L
protein to cause differentiation of PC12 cells was examined. In
PC12 cells, expression of activated Ras proteins is character-
ized by the cessation of mitosis, unique rearrangements of the
actin cytoskeleton, and extension of neuron-like processes in a
program of events similar to those triggered by exposure to
nerve growth factor (32, 33). Only activated forms of Ras have
been found to produce this response, whereas normal cellular
Ras has no effect (34–36). More important, Ras must be
membrane-bound to cause neurite extension, as non-lipi-
dated forms, even if activated, are incapable of triggering
differentiation (37, 38).
PC12 cells transfected with DNA encoding a cellular, nor-
mally lipidated form of Ha-Ras (p21WT) continued to prolifer-
ate and showed the limited adherence and round shape char-
acteristic of the parental PC12 cells (Fig. 5, a and b). PC12 cells
transfected with DNA encoding the constitutively active, pre-
nylated and palmitoylated Ha-Ras61L protein developed neu-
rites that attained a length of greater than two cell bodies after
;48 h (see Fig. 5 legend). There were two or occasionally three
of these axon-like extensions/cell, which continued to elongate
over the next 2–3 days. However, at 48 h, only 21% of these
extensions were longer than 100 mm (see Fig. 5 legend). The
processes were smooth and, during the first days, generally
extended linearly, with a single growth cone on each and little
branching (Fig. 5e). The amount of DNA necessary to generate
this rate and extent of response by Ha-Ras61L was titrated and
found to require 1 mg of DNA. The morphology of PC12 cells
expressing Ha-Ras61L was similar to that of the cells treated
with 50 ng/ml nerve growth factor, although the nerve growth
factor response required 2–3 days for neurite extension to be
established and progressed more slowly, over 8–10 days (data
not shown).
In contrast, PC12 cells transfected with 1 mg of DNA encod-
ing the Ext61L protein developed multitudes of neurites (Fig.
2B). As little as 50 ng of DNA encoding the Ext61L protein
caused development of visible neurites as early as 24 h after
transfection (Fig. 5f). These processes were longer than those
produced by 61L and extended rapidly, exceeding within 2 days
even the final length of those in the 61L cultures (Fig. 5e). Cells
expressing the Ext61L protein often produced four or five ex-
tensions/cell, and 84% of these extensions were longer than 100
mm 48 h after transfection (see Fig. 5 legend). Furthermore, as
the differentiation of these cells progressed, the extensions
became highly branched, wandered in several directions, and
displayed numerous fine filopodia along their length. In addi-
tion, Ext61L brought about a flattening of the cell body, with
large lamellipodia, areas of adherence, and veils of attachment.
A prominent feature of cells expressing the Ext61L protein was
the accumulation of numerous large, intracellular vesicles. The
biological activity of Ext61L was therefore unexpectedly ro-
bust, and the morphological changes it caused were an exag-
gerated version of those caused by the normally lipidated Ha-
Ras61L protein.
To determine if the conspicuous activity of Ext61L could be
ascribed to particularly efficient protein expression, the
TABLE I
Transformation of NIH 3T3 cells by ExtRas proteins
Each DNA was ligated into the expression vector pcDNA3 and intro-
duced into NIH 3T3 cells using the calcium phosphate transfection
technique. Amounts of DNA used were varied from 20 to 100 ng/plate
for the Ext61L and 61L constructs; ExtWT and p21WT DNAs were
tested at 500, 1000, and 2000 ng/plate. Foci of transformed cells were
counted after 10–14 days. Experiments with Ext61L and ExtWT were
repeated four separate times. Data shown are the averages of the
number of foci counted, normalized to represent 1 mg of DNA.




p21WT 2 FIG. 5. ExtRas proteins cause neurite outgrowth in PC12 cells.
PC12 cells were transfected with the indicated amounts of various Ras
DNAs: a, parental cells; b, 10 mg of p21WT; c, 1 mg of Ext61L(C181S/
C184S/C186S); d, 1 mg of ExtWT(C181S/C184S/C186S); e, 1 mg of Ha-
Ras61L; f, 10 ng of Ext61L; g, 200 ng of ExtWT. Cells were photo-
graphed using phase-contrast optics 4 days post-transfection. Scale
bars 5 50 mm. On day 2, when outgrowths could be clearly assigned to
an individual cell body, cell images were captured on computer, and
extensions on 50 transfected cells expressing either Ha-Ras61L or
Ext61L were measured. A successfully transfected cell was defined as a
cell having a flattened and adherent cell body and at least one visible
outgrowth. Cotransfections of Ext61L and b-galactosidase expression
plasmids showed that .70% of the cells were transfected and that
.95% of these transfected cells possessed neurites. Ext61L cells had an
average of 3.4 extensions/cell, and 84% of these extensions were longer
than 100 mm. For cells expressing Ha-Ras61L, the average number of
outgrowths was 2.0, but only 21% of these were longer than 100 mm.
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amount of Ext61L or Ha-Ras61L in the membrane/detergent
fraction prepared from differentiated PC12 cells transfected as
described for Fig. 5 was examined more closely. In the Ext61L-
expressing cells, the amount of protein in the detergent fraction
was less than the amount present in the detergent fraction of
the Ha-Ras61L-expressing cells (Fig. 3B). However, despite
expressing smaller amounts of membrane-associated protein,
the culture transfected with Ext61L DNA exhibited more ex-
travagant neurite extensions than the parallel culture of cells
expressing Ha-Ras61L protein (Fig. 5, e and f). Additional
experiments using an even smaller amount of Ext61L DNA (10
ng) showed that exaggerated neurite morphology was still pro-
duced when the total amount of Ext61L protein (cytosolic 1
aqueous 1 detergent) was much less (approximately one-tenth)
than the total amount of protein that was present in the par-
allel culture transfected with Ha-Ras61L DNA (data not
shown). Thus, even with smaller amounts of membrane-bound
protein, Ext61L continued to exceed Ha-Ras61L activity and to
display unusual characteristics in the neurites it produced.
Therefore, in two assays that test quite different outcomes of
Ha-Ras activity, transformation and differentiation, there was
certainly no evidence that the residues appended to the C
terminus or the large amount of cytosolic Ext61L protein di-
minished biological function.
The Cellular Form of the Extension Protein ExtWT Causes
Differentiation of PC12 Cells—The unusual activity of the
Ext61L protein in PC12 cells raised the possibility that the
cellular (wild-type) form of ExtRas might generate a response
in PC12 cells. Transfection of PC12 cells with as little as 250 ng
of ExtWT DNA caused production of neurites, with an acceler-
ated time course that was intermediate between that of Ha-
Ras61L and Ext61L and with a morphology characteristic of
and as unusual as the Ext61L protein (Fig. 5g). This amount of
ExtWT DNA caused production of protein amounts that were
less than those produced in parallel cultures expressing Ha-
Ras61L protein (data not shown). The quite appreciable activ-
ity of the ExtWT protein contrasted with the complete inactiv-
ity of normal Ha-Ras with the native C-terminal residues and
lipid modifications. Transfection of cultures with 40 times
larger amounts of DNA (10 mg) for p21WT produced abundant
protein expression (data not shown), but caused no neurite
extension (Fig. 5b) (36). Thus, these changes in the Ha-Ras C
terminus appeared to have also increased the biological activity
of a cellular form of Ha-Ras to cause PC12 cell differentiation.
Palmitoylation Is Required for ExtRas-mediated Differentia-
tion of PC12 Cells and Membrane Localization—Previous ob-
servations have established that prenylation and either palmi-
toylation or a stretch of basic amino acids are required for
membrane localization and biological activity of Ras proteins
(2, 10). To determine if the exaggerated activity of Ext61L could
be ascribed to the polylysine motif, ExtRas proteins that could
not be palmitoylated (Ext61L(C181S/C184S/C186S) and
ExtWT(C181S/C184S/C186S)) were constructed. The C181S/
C184S/C186S mutants were unable to induce differentiation of
PC12 cells (Fig. 5, c and d). Thus, the C-terminal polylysine
motif, without palmitate, did not support Ha-Ras biological
activity.
The subcellular localization of Ext61L and ExtWT(C181S/
C184S/C186S) was also examined by subcellular fractionation
with Triton X-114 phase separation. As shown in Fig. 3, the
ExtRas(C181S/C184S/C186S) proteins, which lack palmitates
but retain the lysines, were localized completely to the cyto-
plasm. Thus, the polylysines alone were not sufficient to main-
tain association of ExtRas(C181S/C184S/C186S) with the
plasma membrane, and stable membrane attachment of
ExtRas appeared to require palmitoylation.
Ext61L and ExtWT Bind GTP/GDP Appropriately—One
possible explanation for the pronounced activity of the ExtWT
and Ext61L proteins was that the changes at the C terminus
altered access of nucleotide exchange proteins or GTPase-acti-
vating proteins, which regulate the ability of Ha-Ras to bind
GTP and allowed the accumulation of the active form of these
proteins, especially ExtWT. To test if the levels of GTP bound
to ExtRas proteins were elevated, transfected PC12 cells were
labeled with 32Pi, and radioactive nucleotides bound to Ha-Ras
immunoprecipitates were separated by thin-layer chromatog-
raphy. In differentiated PC12 cells, 83% of the expressed 61L
protein and 82% of the Ext61L protein were in the GTP-bound
form (Fig. 6). In a second experiment, nucleotides bound to
cytosolic and membrane-associated forms of the proteins were
analyzed. The portion of the membrane-bound form of Ext61L
that had GTP (82%) was the same as the portion that bound
GTP in the cytosolic form (data not shown), suggesting that
GTPase-activating proteins were equally (in)effective on the
Ext61L protein in either location. Thus, both the soluble and
membrane-bound forms of Ext61L were, to an extent similar to
Ha-Ras61L, predominantly in the active conformation.
For the ExtWT protein, 8% of the protein contained GTP
(Fig. 6). This is equivalent to the portion found using this
isolation protocol on an overexpressed, cellular Ha-RasWT in
NIH 3T3 cell lines, where 8% was also in the GTP-bound form
(data not shown). Again, both cytosolic and membrane-associ-
ated ExtWT proteins appeared to have similar GTP/GDP ratios
(data not shown). Thus, the ExtWT protein was primarily in
the GDP state, as appropriate for a cellular form of Ha-Ras,
and showed no evidence that the altered C terminus had in-
creased interactions with exchange factors or decreased inter-
actions with GTPase-activating protein(s) to the point that
could explain its potent differentiating activity.
DISCUSSION
Targeting and stable localization of Ha-Ras to the plasma
membrane coincide with acquisition of biological activity. How-
ever, the possibility of distinct or independent contributions of
the two lipid modifications to targeting, binding, or function
has been difficult to examine. We have developed a unique form
of Ha-Ras that can be palmitoylated without the requirement
for prior farnesylation. The C-terminal changes in this protein
do not appear to have altered the basic GTP binding properties
of this protein, and the protein causes unexpectedly potent
FIG. 6. Identification of the nucleotide bound to ExtRas pro-
teins. Transfected PC12 cells were radiolabeled with 32Pi for 4 h, and
Ha-Ras was collected by immunoprecipitation. Protein-associated ra-
dioactive GTP and GDP were released, separated by thin-layer chro-
matography, and detected by autoradiography. The data were quanti-
tated by densitometry, and the ratio of GTP to the total of GTP plus
GDP was determined. Lane 1, Ha-Ras61L; lane 2, Ext61L; lane 3,
ExtWT.
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biological function of two quite different types. These studies
support the possibility that palmitate may have structural and
biological roles of its own, independent of isoprenoid.
Requirements for Palmitate Attachment and Removal—To
produce a palmitoylated but non-prenylated protein, an artifi-
cial polylysine domain was attached to the C terminus of Ha-
Ras. The polylysine tail was designed to be (and was appar-
ently successful as) an ionic platform through which the
otherwise soluble, non-prenylated Ha-Ras protein could ini-
tiate membrane contact and undergo subsequent palmitoyla-
tion, which then promoted tighter and more sustained interac-
tion. This tail motif partially mimics the larger polybasic region
found just internal to the carboxyl terminus of the Ki-Ras4B
protein, which has no cysteines that can be palmitoylated.
However, in Ki-Ras4B, the simple presence of a C-terminal
polybasic domain, without farnesylation, does not support
membrane binding (2, 29, 39, 40).
The ExtRas proteins share several properties with a non-
farnesylated mutant yeast Ras2 protein with the C-terminal
sequence CCIIKLIKRK (mutated CAAX box underlined). This
mutant Ras2 protein is also palmitoylated (at the cysteine
previously used for farnesyl attachment as well as the natural
adjacent site), binds membranes, and is biologically functional
(25). Why having a series of positively charged residues beyond
the natural C-terminal end of Ha-Ras or Ras2 might permit
palmitoylation remains to be studied, but this placement does
appear to be a successful method to circumvent the need for
prenylation and to permit palmitate attachment and may be
applicable to other proteins as well.
The data presented here demonstrate that Ha-Ras can be
palmitoylated at the natural C-terminal sites without being
farnesylated. Our own studies have indicated that palmitoyla-
tion of Ha-Ras, although proposed to be catalyzed enzymati-
cally, has no discernible primary amino acid structure that
functions as a potential signal sequence (11). The successful
palmitoylation of the non-prenylated Ext61L protein clearly
indicates that a farnesyl is not a required part of a recognition
motif for any potential Ha-Ras acyltransferases.
A dynamic balance of addition and removal is a central
property of Ha-Ras palmitate modification and the character-
istic that most clearly differentiates it from prenylation. The
Ext61L protein has three cysteines that are potential sites for
palmitoylation. Whether all of these sites are used or to what
extent each is modified is unknown, as current methods to
directly examine palmitate stoichiometry are unsatisfactory.
The abundant amount of cytosolic Ext61L protein indicates
that palmitoylation of this protein is less complete than that of
the native form. The polylysine extension on Ext61L is com-
patible with dynamic, transient acylation-deacylation and does
not prevent access of thioesterases to the C terminus. Future
studies can now be designed to remove lysine residues and to
replace each cysteine individually to more clearly define fa-
vored sites for palmitate attachment as well as the require-
ments for palmitate removal.
Properties Needed for Membrane Interaction—For Ha-Ras,
farnesyl is a rather poor membrane tether: only about 10% of
the protein is membrane-bound when a farnesyl is the only
lipid present (2, 11). With only palmitate and lysines present,
Ext61L interacts with membranes to a greater extent than
Ha-Ras(C186S), a property presumably due to the combination
of hydrophobic and ionic signals in Ext61L. However, the siz-
able pool of cytoplasmic Ext61L protein, which has the lysines
but no palmitates, suggests that the lysine residues on their
own do not contribute greatly to long-term membrane interac-
tions. The solubility of the mutant Ext61L(C181S/C184S/
C186S) supports this inference, as does the yeast Ras2 exten-
sion protein, where mutation of the cysteines to serines,
leaving the polybasic residues intact, abolishes membrane in-
teraction (25). These results argue that firm membrane inter-
action of an Ha-Ras protein does not require a permanently
attached lipid and that it is largely the palmitates, despite
their continuous cycles of attachment and removal, that sup-
port the stable interaction of the Ext61L protein with mem-
branes. This capacity of palmitates has not previously been
demonstrated. Thus, if palmitates can assume responsibility
for bilayer interactions, farnesyl does not need to be perma-
nently engaged in this function and becomes available for ad-
ditional interactions with proteins within the membrane or
with effectors. These results emphasize that palmitate and
farnesyl may have distinct, perhaps sequential, but comple-
mentary roles in membrane binding and function of Ha-Ras.
However, the combination of palmitates and lysines clearly
is not as efficient as the .95% achieved by the natural farnesyl
plus palmitate modification. One possible explanation for this
modest amount of membrane-bound Ext61L protein is that, in
the absence of a tethering farnesyl, the dynamic turnover of the
palmitates now sets a new, lower equilibrium point for mem-
brane attachment/release. The amount of membrane-bound
ExtRas is likely to depend heavily on the rates of palmitoyla-
tion and deacylation. The development of the ExtRas proteins
should now allow events that may regulate Ha-Ras palmitoy-
lation and membrane interactions to be addressed more
clearly.
Other C-terminal alterations in Ha-Ras have produced pro-
teins that are located on intracellular, possibly Golgi, mem-
branes (11). Such data suggest that unexplored determinants
of plasma membrane targeting are located in the C terminus of
Ha-Ras and may include the sites of palmitoylation. That re-
gion remains unaltered in the Ext61L protein and may con-
tinue to impart specific plasma membrane interaction signals
because immunofluorescence showed strong plasma membrane
localization and no staining of internal membranes. Additional
studies can now determine if the GTP-bound Ext61L and GDP-
bound ExtWT proteins are associated with membrane subdomains
(e.g. “rafts” or caveolae) and how their localization compares with
that of Ha-Ras protein with the natural lipid modifications. The
ExtRas proteins will permit study of the specific roles of palmitate
and farnesyl in this compartmentation.
Influence of the Ha-Ras C Terminus on Biological Function—
Early studies had suggested that the C-terminal lipids on Ras
proteins were only a convenient method for membrane attach-
ment, were not required for more specific interactions with
membrane or effector proteins, and were therefore only indi-
rectly involved in signal transduction. This inference was based
on studies in which leader sequences (N-myristoylation or an
actual transmembrane domain (41)) were used to target non-
farnesylated Ha-Ras(C186S) proteins to the plasma mem-
brane. Such chimeric proteins possessed quite good activity in
transformation of NIH 3T3 cells, demonstrating that the bio-
logical function of transformation did not specifically need far-
nesyl. However, one group reported that the membrane binding
provided by the N-myristoyl group re-established palmitoyla-
tion of the two C-terminal Cys-181 and Cys-184 residues (23).
That finding remains unconfirmed, as conflicting results have
been reported (11), but is potentially important because it
implies that acylation may have a direct impact on biological
function.
Two additional observations have also implicated the C-
terminal lipids in roles beyond membrane anchoring. First,
N-myristoylation of a cellular form of non-prenylated Ha-
Ras(C186S) potentiated the low transforming activity of the
normal protein almost 1000-fold (26). This implies that this
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particular N-terminal surrogate membrane targeting system
releases cellular Ha-Ras from a restraint that usually keeps
such oncogenic activity in check.
Second, some studies have inferred that Ha-Ras lipids, par-
ticularly farnesyl, interact directly with proteins, rather than,
or in addition to, a membrane bilayer. A farnesyl has recently
been reported to be required for interaction of Ha-Ras with a
plasma membrane protein (14). A farnesyl-dependent interac-
tion between Ha-Ras and the zinc finger (cysteine-rich domain)
of Raf-1 kinase has also been suggested to occur (15, 42). In
these instances, the non-farnesylated forms that were used
also lacked palmitate, so the contribution or requirement of the
acyl group to these interactions remains to be answered. In the
yeast Ras2 protein, farnesyl, but not palmitate, is reported to
be required for Ras-mediated signal transduction, where it
plays an essential, possibly direct role in promoting protein/
protein interactions between yeast Ras and a regulatory pro-
tein of adenylyl cyclase, its downstream effector (20). All these
results imply that both C-terminal lipids may have important
roles in Ha-Ras effector interaction and function that await
exploration.
The strong differentiating and transforming activity of
Ext61L was somewhat surprising because previous studies had
found that mutant Ras proteins that were poorly membrane-
bound were also poorly transforming (10, 11). The potency of
Ext61L could not be explained by abnormally stable palmitoy-
lation of the membrane-bound form or by a greater amount of
protein in membranes. Even when lesser amounts of mem-
brane-associated protein were present, Ext61L still caused a
more rapid and exceptional differentiation of PC12 cells than
61L protein. The morphology of NIH 3T3 cells expressing
Ext61L is also distinguishable from that of cells expressing
authentic 61L. These unusual morphologies suggest that cy-
toskeletal pathways are perturbed. Studies are underway to
determine if Ext61L interacts with and activates the same
pathways as Ha-Ras61L with the native C terminus and lipids
or if the introduction of the basic residues has altered or added
effector proteins to the repertoire of Ha-Ras partners. The
change in lipidation of the Ext61L protein may also influence
the (sub)membrane localization of the protein and thus indi-
rectly affect its access to regulatory or effector proteins.
The possibility that interactions with effectors or membranes
may have been changed in the ExtRas proteins is supported by
the unexpected activity of ExtWT. Non-activated or wild-type
forms of Ha-Ras do not normally induce differentiation of PC12
cells (34, 43), yet the ExtWT protein produced robust neurite
extension. More important, the vigorous biological activity of
the ExtWT protein in PC12 cells did not seem to be caused by
decreased GTPase activity or altered interactions with guanine
nucleotide exchange factors or GTPase-activating proteins,
which regulate Ha-Ras/GTP binding, as the ExtWT protein
was GDP-bound to the same extent as the normal cellular form.
The ExtRas proteins appear to be a new type of activated
Ha-Ras because activation has occurred 1) by a mechanism
that does not involve changes in GTP binding or hydrolysis and
2) through alteration of a domain previously not considered to
be directly involved in signal transduction. The exaggerated
activity of the Ext61L protein further emphasizes that muta-
tion of the C terminus can have a direct (stimulatory) effect on
two types of Ha-Ras biological activity. These results suggest
an expanded model for Ras activation: that functional interac-
tions of the ExtRas proteins may be controlled, in addition to
the GTP-sensitive switch regions of the protein, by the C-
terminal domain. Studies with the ExtRas proteins will be
valuable for determining how this activation arises and if Ha-
Ras with its natural lipid modifications also utilizes the C-
terminal domain and its attached lipids in an active role in
Ras-mediated signal transduction.
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